The main IPA analyses predicted outcomes due to combined downregulation of c-MET and PTGS2 by OC treatment in NSCLC include the suppression of tumor cell proliferation, migration and metastasis and induction of tumor cell death (Figure 8C). This evidence concerns the gene MET and non-small cell lung carcinoma.